Related Experiment Video
Updated: Aug 24, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Antiretrovirals, part 1: overview, history, and focus on protease inhibitors
Gary H Wynn1, Michael J Zapor, Benjamin H Smith
1Department of Medicine, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.
Insights
This review introduces HIV/AIDS antiretroviral drugs, focusing on protease inhibitors. Understanding these medications is crucial for all healthcare professionals managing HIV/AIDS patients.
Area of Science:
- Pharmacology
- Infectious Diseases
- Virology
Background:
- Overview of HIV/AIDS history and the evolution of treatment.
- Introduction to the significance of antiretroviral therapy (ART) for non-specialists.
- Categorization of major HIV drug classes.
Observation:
- Detailed examination of protease inhibitors (PIs) as a key component of HAART.
- Exploration of the four primary classes of HIV medications: PIs, NRTIs, NNRTIs, and fusion inhibitors.
- Focus on the mechanism of action for PIs.
Findings:
- Summary of the diverse mechanisms of action for protease inhibitors.
- Identification of common side effects and toxicities associated with PI therapy.
- Analysis of potential drug interactions involving protease inhibitors.
Implications:
- Emphasizes the importance of understanding PI pharmacology for comprehensive patient care.
- Highlights the need for interdisciplinary collaboration in managing HIV/AIDS.
- Provides foundational knowledge for further reviews on other HIV drug classes.
Abstract:
This column is the first in a series on HIV/AIDS antiretroviral drugs. This first review summarizes the history of HIV/AIDS and the development of highly active antiretroviral therapy (HAART) and highlights why it is important for non-HIV specialists to know about these drugs. There are four broad classes of HIV medications used in varying combinations in HAART: the protease inhibitors, nucleoside analogue reverse transcriptase inhibitors, the non-nucleoside reverse transcriptase inhibitors, and cell membrane fusion inhibitors. This paper reviews the mechanism of action, side effects, toxicities, and drug interactions of the protease inhibitors.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Retroviruses
Size and Structure of Viral Genomes

